Dexcom G7 Continuous Glucose Monitoring System Receives European CE Mark

DexCom Inc's DXCM Dexcom G7 Continuous Glucose Monitoring (CGM) System has secured European CE Mark for people with diabetes aged two years and older, including pregnant women.

• The Company adds that the Dexcom G7 all-in-one wearable warms with 30-minute sensor warm-up is faster than any other CGM on the market, sending real-time glucose readings automatically to a compatible smart device or receiver, with no fingersticks required.
• Dexcom G7 also offers a suite of customizable alerts that can warn of high or low glucose levels and help users spend more time in range.
• Related: DexCom's Glucose Monitoring System Snags Breakthrough Device Tag For Hospital Use.
• The remote monitoring enables users to share glucose data with ten followers.
• Dexcom is also working closely with its insulin pump partners to integrate Dexcom G7 into current and future automated insulin delivery systems as quickly as possible.
• Price Action: DXCM shares are down 0.17% at $389.58 during the market session on the last check Monday.